Brain Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- Adults diagnosed with glioblastoma (a type of brain tumour) that has come back, and where the tumour has a specific characteristic called "IDH wildtype"
- The tumour has returned after completing the standard first treatment, which involves both radiation therapy and chemotherapy
- The treating doctor has determined that a medication called bevacizumab is a suitable treatment option
- Brain scans using MRI can be used to monitor the person's condition
- The person has a general health and functioning score of at least 60% on a standard medical scale (meaning they are able to care for themselves and carry out some normal activities) (confirm with trial site)
- The person has provided written, signed agreement to participate in the trial
Who may not be able to join:
- People who are pregnant or currently breastfeeding
- People whose life expectancy is estimated to be less than 3 months
- People who have already received bevacizumab as part of their first course of treatment
- People who have another serious, life-threatening illness at the same time
- People who are under legal protection or guardianship (confirm with trial site)
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Emeline Tabouret, AP-HM
Phone: 0491385500
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
correlation between soluble CD146 plasma value and patient response (RANO)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.